|
Manual analysis threshold
|
10% automated threshold
|
RFC threshold
|
---|
|
HR
|
95% CI
|
P value
|
HR
|
95% CI
|
P value
|
HR
|
95% CI
|
P value
|
---|
Cohort I (n = 179)
| | | | | | | | | |
ER
| | | | | | | | | |
OS
|
0.259
|
0.127 to 0.530
|
0.001
|
0.154
|
0.067 to 0.355
|
0.002
|
0.235
|
0.116 to 0.473
|
0.001
|
PR
| | | | | | | | | |
OS
|
0.307
|
0.158 to 0.597
|
0.001
|
0.361
|
0.183 to 0.712
|
0.01
|
0.386
|
0.197 to 0.756
|
0.02
|
Cohort II (n = 564)
| | | | | | | | | |
ER
| | | | | | | | | |
OS
|
0.62
|
0.465 to 0.826
|
0.006
|
0.68
|
0.509 to 0.907
|
0.009
|
0.631
|
0.480 to 0.830
|
0.001
|
BCSS
|
0.677
|
0.494 to 0.928
|
0.006
|
0.664
|
0.492 to 0.898
|
0.008
|
0.592
|
0.445 to 0.787
|
< 0.001
|
RFS
|
0.714
|
0.540 to 0.943
|
0.009
|
0.797
|
0.603 to 1.054
|
0.11
|
0.701
|
0.538 to 0.914
|
0.009
|
PR
| | | | | | | | | |
OS
|
0.647
|
0.483 to 0.867
|
0.004
|
0.719
|
0.538 to 0.961
|
0.026
|
0.705
|
0.524 to 0.947
|
0.020
|
BCSS
|
0.602
|
0.445 to 0.814
|
0.001
|
0.7
|
0.518 to 0.947
|
0.020
|
0.673
|
0.495 to 0.916
|
0.012
|
RFS
|
0.73
|
0.549 to 0.972
|
0.03
|
0.797
|
0.603 to 1.053
|
0.790
|
0.791
|
0.593 to 1.054
|
0.109
|
- HR, hazard ratio; CI, confidence interval; OS, overall survival; BCSS, breast cancer-specific survival; RFS, recurrence-free survival.